Sax Wealth Advisors LLC acquired a new position in Plexus Corp. (NASDAQ:PLXS – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,236 shares of the technology company’s stock, valued at approximately $583,000.
A number of other large investors also recently bought and sold shares of PLXS. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Plexus during the second quarter worth $32,000. Kilter Group LLC bought a new stake in Plexus during the 2nd quarter valued at $40,000. Integrated Wealth Concepts LLC purchased a new position in shares of Plexus in the 2nd quarter valued at $51,000. Persistent Asset Partners Ltd purchased a new position in shares of Plexus in the 2nd quarter valued at $71,000. Finally, Caitlin John LLC purchased a new position in shares of Plexus in the 2nd quarter valued at $74,000. Institutional investors own 94.45% of the company’s stock.
Plexus Stock Down 2.9%
NASDAQ:PLXS opened at $238.71 on Friday. The company has a market cap of $6.39 billion, a PE ratio of 36.24 and a beta of 0.88. Plexus Corp. has a twelve month low of $132.03 and a twelve month high of $307.06. The company has a current ratio of 1.49, a quick ratio of 0.72 and a debt-to-equity ratio of 0.06. The company’s 50 day moving average is $254.29 and its two-hundred day moving average is $257.61.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. The business had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. Plexus’s revenue for the quarter was up 28.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Analysts anticipate that Plexus Corp. will post 7.13 EPS for the current year.
Analysts Set New Price Targets
Several research analysts have recently commented on PLXS shares. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. KeyCorp raised Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price objective on the stock in a research report on Monday, September 21st. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research report on Sunday, October 4th. Needham & Company LLC reiterated a “buy” rating and issued a $310.00 target price on shares of Plexus in a research note on Friday, August 14th. Finally, Stifel Nicolaus lifted their target price on Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. One equities research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $276.86.
Read Our Latest Stock Report on Plexus
Insider Activity
In other news, Director Karen Rapp sold 500 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $240.87, for a total transaction of $120,435.00. Following the sale, the director directly owned 7,535 shares of the company’s stock, valued at $1,814,955.45. The trade was a 6.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd Kelsey sold 1,500 shares of the company’s stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $242.41, for a total value of $363,615.00. Following the completion of the transaction, the chief executive officer directly owned 64,388 shares in the company, valued at approximately $15,608,295.08. The trade was a 2.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,500 shares of company stock valued at $1,960,520 over the last ninety days. 1.78% of the stock is currently owned by insiders.
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is an electronics manufacturing services and product development company headquartered in Neenah, Wisconsin. The company helps customers design, engineer, manufacture and service complex electronic products, offering capabilities that span product development, printed circuit board assembly, systems integration, testing, supply-chain management and aftermarket support.
Plexus serves customers in markets including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.
Featured Stories
- Five stocks we like better than Plexus
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
